Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.

× No keyword cloud information.

12 in total

Review 1. Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors: Charles Feldman; Ronald Anderson
Journal: Drugs Date: 2011-01-22 Impact factor: 9.546

Review 2. Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections.

Authors: Stephen Brunton; Paul Iannini
Journal: MedGenMed Date: 2005-12-07

3. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia.

Authors: Mark I Neuman; Meera Kelley; Marvin B Harper; Thomas M File; Carlos A Camargo
Journal: J Emerg Med Date: 2007-03-30 Impact factor: 1.484

4. Bacteremic pneumococcal pneumonia associated with macrolide failure.

Authors: J Dylewski; R Davidson
Journal: Eur J Clin Microbiol Infect Dis Date: 2006-01 Impact factor: 3.267

5. Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae.

Authors: Dorothea Zähner; Xiaoliu Zhou; Scott T Chancey; Jan Pohl; William M Shafer; David S Stephens
Journal: Antimicrob Agents Chemother Date: 2010-05-24 Impact factor: 5.191

6. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.

Authors: Michael Green; Coburn Allen; John Bradley; Barry Dashefsky; Janet R Gilsdorf; Mario J Marcon; Gordon E Schutze; Clay Smith; Emmanuel Walter; Judith M Martin; Kathryn A Edwards; Karen A Barbadora; Renee M Rumbaugh; Ellen R Wald
Journal: Antimicrob Agents Chemother Date: 2005-06 Impact factor: 5.191

In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.

Review 1. Bacteraemic pneumococcal pneumonia: current therapeutic options.

Review 2. Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections.

3. Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia.

4. Bacteremic pneumococcal pneumonia associated with macrolide failure.

5. Human antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae.

6. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.

7. Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancer.

Review 8. Antimicrobial resistance in Haemophilus influenzae.

Review 9. Hidden epidemic of macrolide-resistant pneumococci.

10. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001.